Cogene Ventures is the famous VC, which was founded in 2000. The main department of described VC is located in the Houston. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 7 partakers. Despite the Cogene Ventures, startups are often financed by MDS Capital, U.S. Venture Partners (USVP), RBC Venture Partners. The meaningful sponsors for the fund in investment in the same round are Vulcan Capital, U.S. Venture Partners (USVP), Schroder Ventures. In the next rounds fund is usually obtained by Sofinnova Investments, RCT BioVentures, Novartis Venture Fund.
Among the various public portfolio startups of the fund, we may underline Catalyst Biosciences, Raven Biotechnologies, Neuromed Pharmaceuticals The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Life Science, Health Care. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Opposing the other organizations, this Cogene Ventures works on 51 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2011. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2003. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
Funds with similar focus
Fund Name | Location |
ABR Capital Management | California, San Francisco, United States |
Agile Equity | New York, New York, United States |
Beijing Falcon Investment | Beijing, Beijing, China |
Burnham Holdings | Lancaster, Pennsylvania, United States |
Center for Innovation | Arlington, Texas, United States |
Charter Life Sciences | California, Santa Clara, United States |
Christie Digital Systems USA | California, Cypress, United States |
General Global Capital | - |
Mingde Zhiyuan Touzi | China, Guangdong, Tianjin |
MyEG Capital | Malaysia, Petaling Jaya, Selangor |
Nex Cubed | California, San Francisco, United States |
One Planet | California, United States, Walnut Creek |
Oxygen Capital Partners, LLC | California, Santa Monica, United States |
Shanhang Capital Investment | - |
Talk City | Massachusetts, North Andover, United States |
Tsukuba Exceed Fund | - |
Zhonghua Chuangxin Jijinhui | - |
ZRC Capital | Beijing, China, Haidian |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MacroGenics | $30M | 15 Oct 2004 | Maryland, United States | ||
Rejuvenon | $37M | 23 Jun 2004 | The Woodlands, Texas, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States | ||
Neuromed Pharmaceuticals | $32M | 04 Nov 2003 | Vancouver, British Columbia, Canada | ||
Catalyst Biosciences | $60M | 20 Mar 2003 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MacroGenics | $30M | 15 Oct 2004 | Maryland, United States | ||
Rejuvenon | $37M | 23 Jun 2004 | The Woodlands, Texas, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States | ||
Neuromed Pharmaceuticals | $32M | 04 Nov 2003 | Vancouver, British Columbia, Canada | ||
Catalyst Biosciences | $60M | 20 Mar 2003 | South San Francisco, California, United States |